SYNOPSIS Two methods for the assay of rifampicin in serum are described. The first is a conventional plate diffusion method, measuring concentrations down to 0-02 /.Lg/ml, and the second a chemical extraction followed by measurement of the inhibition of uptake of 14C-uridine by Staphylococcus aureus, which estimates in the range of 0-02 to 0 001 ,tg/ml. The methods were used to measure serum concentrations in man following doses of about 1050 mg and 75 mg rifampicin.
The use of rifampicin in intermittent regimens for the treatment of tuberculosis has the advantages of reducing the high cost of the drug and allowing full supervision of drug taking but is accompanied by side effects, probably immunological in origin (Poole, Stradling, and Worlledge, 1971; Aquinas, Allan, Horsfall, Jenkins, Wong, Girling, Tall, and Fox, 1972) . Amongst various methods under investigation which might eliminate these side effects is the prescription of a small daily dose of rifampicin to be taken on the days between the larger therapeutic intermittent doses. Such an attempt to induce immunological tolerance is currently under study in Hong Kong using a daily dose of 75 mg rifampicin and in Singapore using 25 mg. The preliminary results of the study in Hong Kong suggest that administration of the small daily dose in between weekly doses of 900 to 1200 mg reduced the incidence of the 'flu' syndrome (Hong Kong Tuberculosis Treatment Services/British Medical Research Council, 1974) . The serum concentrations attained were studied as theyare fundamental to an interpretation of the results. Since the small daily doses used in the two studies were expected to produce concentrations of rifampicin only briefly measurable by conventional plate diffusion assays, a more sensitive method of assay was developed. In this method, serum proteins were precipitated with methanol and rifampicin was then extracted into chloroform and thence into water with the aid of n-heptane. The aqueous extract was evaporated to dryness and dissolved in nutrient broth seeded with Staphylococcus aureus. The rifampicin concentration could be measured as inhibition of the uptake of uridine-C14 into the staphylococcal RNA, since it inhibits Received for publication 14 February 1974. bacterial deoxyribonucleic acid-dependent ribonucleic acid (RNA) polymerase (RNA nucleotidyl transferase E.C.2.7.7.6) (Hartmann, Honikel, Knusel, and Nuesch, 1967; Wehrli, Knusel, Schmid, and Staehelin, 1968; Sippel and Hartmann, 1968; Umezawa, Mizuno, Yamazaki, and Nitta, 1968) . The present report describes a conventional plate assay which can measure down to 0-02 jug/ml rifampicin, the new method which can measure between 0-02 and 0-001 jig/ml, and the serum concentrations obtained with the large and the small doses of rifampicin in patients in the Hong Kong study.
Methods

ASSAY ORGANISM
Staphylococcus aureus (Staphylococcus subgroup I, NCITC 10702), resistant to streptomycin and other antibiotics (Mitchison, Allen, and Miller, 1970) , was used as the test organism in both methods. Samples of an overnight culture in nutrient broth (Oxoid, no. 2) were stored at -196°C and an ampoule was thawed for each assay.
PLATE DIFFUSION ASSAY
Seeded assay medium was prepared by adding 10 pJ culture to 100 ml Bacto antibiotic medium no. 1 (Difco, Detroit), modified by the addition of 3 ml M KH2 P04, and was dispensed in 10-ml volumes into 9 cm diameter plates. Four Incorporation of uridine Each tube containing dried extract received 0 4 ml of buffered medium pH 6 4, prepared by mixing 5 ml 0 5 M tris maleate buffer pH 6-6, 25 ml nutrient broth (Oxoid no. 2) and 0-6 ml 0-2 N HCI, and the contents were dissolved by agitating the tube on a Vortex mixer. To each tube was added 01 ml of a mixture of 4-5 ml nutrient broth, 0 3 ml of the culture of Staph. aureus, and 10 ,uC in 0-2 ml 14C-uridine (uridine -2-14C, specific activity about 60,uC/mM, Radiochemical Centre, Amersham). After incubation in a water bath for three hours at 37°C, incorporation was terminated by the addition of 5 ml 50% (w/v) trichloracetic acid. The organisms were collected on glass fibre paper discs (Whatman, grade GF/A) dried and counted in toluene containing 7 g/l 2(4-tert-butylphenyl) 5 (4-biphenylyl) 1-3-4 oxadiazole in an Intertechnique ABAC 40 scintillation counter. Serum without rifampicin yielded about 60 000 cpm and serum with an excess of rifampicin about 120 cpm. transformed to log -R)' where R is the ratio URIDINE UPTAKE ASSAY Standards Standards were prepared containing 20, 10, 5, 2-5, and 1 25 ng/ml rifampicin in normal human serum. One sample (2 ml) of each standard and two samples of serum without rifampicin were included in each batch of assays.
Extraction
Samples of 2 ml serum, in a glass stoppered tube, were mixed with 6 ml methanol to precipitate protein and strip off bound rifampicin. After centrifugation at 0°C, 6 ml of supernatant was removed to a fresh tube, to which was added 3 ml chloroform and 1-5 ml 150 ammonium sulphate solution. After mixing, 3 ml of the lower chloroform phase was transferred to another tube and 4 ml n-heptane added. Council, 1974) . These patients received at weekly intervals a dose of rifampicin of about 23 mg/kg body weight (900 mg for patients of less than 40 9 kg, 1050 mg for 40 9-49 5 kg, and 1200 mg for 50 kg or more), 90 mg/kg ethambutol, and approximately 66 mg/kg pyrazinamide given at the same time. On each day between the weekly doses they were also given a daily supplement of either 75 mg rifampicin or of a matching placebo. Blood was collected from patients allocated to the rifampicin-containing supplement after they had received at least one month of chemotherapy. Samples from the same patients were taken at intervals over a 48-hour period following one of the high weekly doses, but omitting the supplement during the collection period, and over a 24-hour period after a dose of supplement on the sixth day after the high weekly dose. The timing of rifampicin dosage in relation to food was 459 the same as in the main study. The high weekly doses were given one and a quarter hours after a light breakfast. The supplement was given in the morning before food, except that patient 9 had taken breakfast one and a half hours previously. Results
ACCURACY OF ASSAYS
In the plate diffusion method, the 95 % fiducial limits of estimates of rifampicin concentrations in individual sera varied from ± 20 % to ± 25 % when the estimate was near the middle of the range of the standard concentrations to ± 40-50% near the extremities of the standard concentration range. The 95% fiducial limits for the uridine uptake method were approximately ± 30 % for values near the middle of the standard concentration range.
RELATIVE ACTIVITIES OF RIFAMPICIN AND DESACETYL RIFAMPICIN
Desacetyl rifampicin (DARMP) is the principal metabolite of rifampicin and retains part of its antibacterial activity (Maggi, Vigevani, and Pallanza, 1968) . However, the relative activity of rifampicin and desacetyl rifampicin varies from organism to organism. A comparison was therefore made of their relative activities against the test Staph. aureus and against Mycobacterium tuberculosis. For the experiment with M. tuberculosis, 11 drugsensitive strains were obtained before chemotherapy from patients in Singapore and Hong Kong and, with strain H37Rv, were tested by the linear diffusion method of Lloyd and Mitchison (1964) . In experiments 1 and 2 concentrations of 0-2, 0-6, and 1-8 ,ug/ml rifampicin and 0-6, 1-8, and 5.4 tLg/ml desacetyl rifampicin were prepared in sterile water or human serum and were assayed in triplicate on plates seeded with Staph. aureus (fig 3) . A good fit was obtained to the lines relating log concentration to zone diameter for rifampicin and desacetyl rifampicin and these lines were parallel, indicating similar diffusion rates of the two compounds. Experiment 3 was conducted in a similar manner with M. tuberculosis. The lines for rifampicin and desacetyl rifampicin again appeared parallel, but there were significant though small departures from linearity (0-025 < p < 0-05), a finding that does not invalidate the estimation of relative activity. Staph. aureus required about 4-5 times as much desacetyl rifampicin as rifampicin to produce zones of the same size ( the high dose and 0 55 ,ug/ml following the supplement dose. Thus the mean peak concentration after the high dose was 34 times higher than after the supplement, although the size of the high dose was only about 14 times larger than the supplement dose. After the high dose of rifampicin, the serum concentrations of the 10 patients fell on average during the periods 4-12, 12-24, 24-32, and 32-48 hours by rates equivalent to half-lives of 4 4, 2 4, 3-7, and 7-2 hours, respectively. Half-lives of 2-2 and The uridine uptake method of assay is considerably more time-consuming and difficult to standardize than the plate assay. This method was developed for measuring concentrations following low doses of rifampicin whose use is being explored in the prevention of toxicity occurring during intermittent dosage of the drug and for other reasons. For most purposes, however, the plate assay, capable of measuring down to 0-02 ,tg/ml, is sufficiently sensitive since the drug is used mainly for the treatment of tuberculosis and the minimal inhibitory concentration for M. tuberculosis is about 0-3 ,ug/ml.
The disproportion between peak serum concentrations and dose size and the slower elimination of rifampicin demonstrated four to eight hours after giving the high dose to the Hong Kong patients is similar to the results previously obtained by Furesz, Scotti, Pallanza, and Marpelli (1967) in man and by Dickinson and Mitchison (1970) in the guinea pig. The slower elimination of the high doses of rifampicin is probably due to saturation of biliary excretion of the drug. However, the differences noted in the initial rates of elimination of the high dose and supplement do not fully account for the disproportion in the peak rifampicin concentrations found. It is therefore suggested that there must be a 'sink', possibly of hepatic origin, that binds a greater proportion of the supplement than of the high rifampicin dose. Subsequent slow release from this sink could explain the differences in the rates of elimination of the two doses occurring at similar serum concentrations. The slower elimination of rifampicin noted after both doses when the serum concentrations fell below 0-04,ug/ml could have been due to release of rifampicin from protein binding. The immunological implications of the measurements of the serum concentrations following the large weekly dose and the smaller daily supplement are discussed elsewhere (Hong Kong Tuberculosis Treatment Services/British Medical Research Council, 1974) .
